US 10053514
Human bispecific EGFRvIII and CD3 antibody engaging molecules
granted A61KA61K2039/505A61P
Quick answer
US patent 10053514 (Human bispecific EGFRvIII and CD3 antibody engaging molecules) held by The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health
- Grant date
- Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00